LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.45 | 27.76 | 2255 | 5745 | 0.3925 | 0.7711 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.45 | 27.76 | 237 | 5745 | 0.0413 | 0.3215 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 56.45 | 27.76 | 2345 | 5745 | 0.4082 | 0.7801 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.15 | 27.76 | 588 | 5906 | 0.0995 | 0.4841 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.15 | 27.76 | 2377 | 5906 | 0.4024 | 0.7779 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.15 | 27.76 | 241 | 5906 | 0.0408 | 0.3224 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 58.15 | 27.76 | 2443 | 5906 | 0.4136 | 0.7842 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 59.85 | 27.76 | 561 | 6062 | 0.0925 | 0.4723 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 59.85 | 27.76 | 2485 | 6062 | 0.4099 | 0.7831 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 59.85 | 27.76 | 253 | 6062 | 0.0417 | 0.3289 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 59.85 | 27.76 | 2546 | 6062 | 0.4200 | 0.7887 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 61.56 | 27.76 | 629 | 6217 | 0.1012 | 0.4914 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 61.56 | 27.76 | 2633 | 6217 | 0.4235 | 0.7916 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 61.56 | 27.76 | 285 | 6217 | 0.0458 | 0.3476 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 61.56 | 27.76 | 2663 | 6217 | 0.4283 | 0.7942 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.26 | 27.76 | 607 | 6465 | 0.0939 | 0.4804 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.26 | 27.76 | 2723 | 6465 | 0.4212 | 0.7917 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.26 | 27.76 | 341 | 6465 | 0.0527 | 0.3757 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 63.26 | 27.76 | 2752 | 6465 | 0.4256 | 0.7941 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.97 | 27.76 | 590 | 6656 | 0.0886 | 0.4720 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.97 | 27.76 | 2838 | 6656 | 0.4263 | 0.7956 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.97 | 27.76 | 333 | 6656 | 0.0500 | 0.3693 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 64.97 | 27.76 | 2887 | 6656 | 0.4337 | 0.7994 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 66.67 | 27.76 | 568 | 6695 | 0.0848 | 0.4644 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 66.67 | 27.76 | 2933 | 6695 | 0.4380 | 0.8019 | MN20160318_Q01 | J22 |